Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-91.77%Free Cash Flow Margin
VS
Market
Sector
Industry
History
$ 0.76Close
$ 0.65 - $ 1.48 52-Week Range
Ticker Information
Ticker
XLOCompany Name
XILIO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQXILIO THERAPEUTICS INC - Free Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XLO - FCF % Historical data
| Date | Free Cash Flow | Free Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -13.77M | -91.77% | $ 15M |
| 3/31/2025 | $ 21.04M | 226.91% | $ 9.27M |
| 12/31/2024 | $ -18.41M | -290.26% | $ 6.34M |
| 9/30/2024 | $ -17.68M | -382.64% | $ 4.62M |
| 6/30/2024 | $ -17.37M | -736.78% | $ 2.36M |
| 3/31/2024 | $ -54.19M | 0% | $ 0 |
| 12/31/2023 | $ -69.11M | 0% | $ 0 |
| 9/30/2023 | $ -74.41M | 0% | $ 0 |
| 6/30/2023 | $ -81.28M | 0% | $ 0 |
| 3/31/2023 | $ -81.92M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- XILIO THERAPEUTICS INC's latest trailing twelve months (TTM) FCF % stands at 0%.
- Over the past 5 years, XILIO THERAPEUTICS INC's average FCF % has been -254.91%.
- The median FCF % for XILIO THERAPEUTICS INC during this period was -290.26%
- XILIO THERAPEUTICS INC reached its highest FCF % over the past 5 years at 226.91%.
- The lowest FCF % recorded by XILIO THERAPEUTICS INC in the same timeframe -736.78%
XILIO THERAPEUTICS INC's FCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF % Benchmarks
Similar metrics to Revenues:
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Free Cash Flow Margin
[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.FCF / Revenues
(=) FCF % FCF % for XILIO THERAPEUTICS INC is calculated as follows: FCF [ $ -38.28M ] / Revenues [ $ 0 ]
(=) FCF % [ 0% ] XLO - Free Cash Flow Margin, Last 5 years
-736.78%
Minimum
Jun 30, 2024
226.91%
Maximum
Mar 31, 2025
-254.91%
Average
-290.26%
Median
FCF % Benchmark AnalysisMarket
The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.88% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
| filtered constituents | 3.18K |
|---|---|
| min | -58.23% |
| max | 68.19% |
| average | 7.88% |
| median | 7.4% |
| std | 19.48% |